Warning: The NCBI web site requires JavaScript to function. more...
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?
Teschendorf D, Link CD.
Mol Neurodegener. 2009 Sep 28;4:38.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
Dimitriadi M, Hart AC.
Neurobiol Dis. 2010 Oct;40(1):4-11. Epub 2010 May 19. Review.
Caenorhabditis elegans Model for Initial Screening and Mechanistic Evaluation of Potential New Drugs for Aging and Alzheimer’s Disease.
Luo Y, Wu Y, Brown M, Link CD.
In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press; 2009. Chapter 16.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.
Silverman GA, Luke CJ, Bhatia SR, Long OS, Vetica AC, Perlmutter DH, Pak SC.
Pediatr Res. 2009 Jan;65(1):10-8. Review.
Caenorhabditis elegans as a model system for triplet repeat diseases.
Voisine C, Hart AC.
Methods Mol Biol. 2004;277:141-60.
Autophagy and cell death in Caenorhabditis elegans.
Samara C, Tavernarakis N.
Curr Pharm Des. 2008;14(2):97-115. Review.
Using Caenorhabditis elegans as a model for aging and age-related diseases.
Olsen A, Vantipalli MC, Lithgow GJ.
Ann N Y Acad Sci. 2006 May;1067:120-8. Review.
Non-developmentally programmed cell death in Caenorhabditis elegans.
Kourtis N, Tavernarakis N.
Semin Cancer Biol. 2007 Apr;17(2):122-33. Epub 2006 Dec 15. Review.
Worm watching: imaging nervous system structure and function in Caenorhabditis elegans.
Dittman J.
Adv Genet. 2009;65:39-78. Review.
C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
Link CD.
Exp Gerontol. 2006 Oct;41(10):1007-13. Epub 2006 Aug 23. Review.
Transgenic C. elegans as a model in Alzheimer's research.
Wu Y, Luo Y.
Curr Alzheimer Res. 2005 Jan;2(1):37-45. Review.
ATP depletion is the major cause of MPP+ induced dopamine neuronal death and worm lethality in alpha-synuclein transgenic C. elegans.
Wang YM, Pu P, Le WD.
Neurosci Bull. 2007 Nov;23(6):329-35.
Watching worms whither: modeling neurodegeneration in C. elegans.
Wolozin B, Gabel C, Ferree A, Guillily M, Ebata A.
Prog Mol Biol Transl Sci. 2011;100:499-514. Review.
Caenorhabditis elegans: a versatile platform for drug discovery.
Artal-Sanz M, de Jong L, Tavernarakis N.
Biotechnol J. 2006 Dec;1(12):1405-18. Review.
Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans.
Syntichaki P, Xu K, Driscoll M, Tavernarakis N.
Nature. 2002 Oct 31;419(6910):939-44.
Anatomy, physiology and pharmacology of Caenorhabditis elegans pharynx: a model to define gene function in a simple neural system.
Franks CJ, Holden-Dye L, Bull K, Luedtke S, Walker RJ.
Invert Neurosci. 2006 Sep;6(3):105-22. Epub 2006 Jul 22. Review.
Molecular mechanisms of developmental neuronal death.
Johnson EM Jr, Deckwerth TL.
Annu Rev Neurosci. 1993;16:31-46. Review.
A worm rich in protein: Quantitative, differential, and global proteomics in Caenorhabditis elegans.
Schrimpf SP, Hengartner MO.
J Proteomics. 2010 Oct 10;73(11):2186-97. Epub 2010 Apr 14. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on